Total skin electron beam therapy
Showing 1 - 25 of >10,000
Sezary Syndrome, Mycosis Fungoides Trial in Stanford (Mogamulizumab, LD TSEBT)
Recruiting
- Sezary Syndrome
- Mycosis Fungoides
- Mogamulizumab
- LD TSEBT
-
Stanford, CaliforniaStanford Cancer Center
Oct 19, 2022
Mycosis Fungoides Trial in Houston (Brentuximab vedotin)
Recruiting
- Mycosis Fungoides
- Brentuximab vedotin
-
Houston, TexasMD Anderson Cancer Center
Oct 14, 2022
Mycosis Fungoides, Cutaneous T Cell Lymphoma Trial (Low-dose total-skin electron-beam therapy, Phototherapy)
Not yet recruiting
- Mycosis Fungoides
- Cutaneous T Cell Lymphoma
- Low-dose total-skin electron-beam therapy
- Phototherapy
- (no location specified)
Jan 24, 2022
Low-Dose Total Skin Electron Therapy in Treating Refractory or
Recruiting
- Recurrent Mycosis Fungoides
- +4 more
- Quality-of-Life Assessment
- Objective Grading of Skin Findings
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Dec 5, 2022
Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor, Refractory Sclerodermatous GVHD Trial in Duarte (procedure,
Not yet recruiting
- Hematopoietic and Lymphoid System Neoplasm
- +2 more
- Biospecimen Collection
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 23, 2022
Cutaneous T-cell Lymphoma Trial in New York (Bexarotene, Total Skin Electron Beam (TSEB))
Recruiting
- Cutaneous T-cell Lymphoma
- Bexarotene
- Total Skin Electron Beam (TSEB)
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Sep 19, 2022
Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III Trial in Knoxville (Pencil Beam Scanning Proton Therapy)
Recruiting
- Breast Cancer
- +3 more
- Pencil Beam Scanning Proton Therapy
-
Knoxville, TennesseeThompson Proton Center
Aug 17, 2023
Psoriasis Vulgaris Trial in Hilversum (595 nm Pulsed dye laser (Candela V-beam perfecta))
Recruiting
- Psoriasis Vulgaris
- 595 nm Pulsed dye laser (Candela V-beam perfecta)
-
Hilversum, Noord-Holland, NetherlandsZBC MultiCare
Jan 23, 2023
Cutaneous T-Cell Lymphomas Trial in Dallas (TSEBT, TSEBT and pembrolizumab)
Withdrawn
- Cutaneous T-Cell Lymphomas
- TSEBT
- TSEBT and pembrolizumab
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Apr 20, 2020
Prostate Cancer Trial in Boston (Flutamide (Eulexin) and Lupron or Zoladex, External Beam Radiotherapy)
Completed
- Prostate Cancer
- Flutamide (Eulexin) and Lupron or Zoladex
- External Beam Radiotherapy
-
Boston, MassachusettsDana-Farber Cancer Institute
Dec 16, 2021
Metastatic Melanoma, Skin Cancer Trial run by the National Cancer Institute (NCI) (drug, biological, radiation)
Active, not recruiting
- Metastatic Melanoma
- Skin Cancer
- Aldesleukin
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Metastatic Malignant Tumor in the Brain Trial in
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +6 more
- Ipilimumab
- +4 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Dec 12, 2022
Pancreas Cancer Trial in United States (IORT)
Recruiting
- Pancreas Cancer
- IORT
-
Irvine, California
- +5 more
Jan 18, 2021
Mycosis Fungoides, Sézary Syndrome Trial in Richmond (TSEB Therapy, Brentuximab vedotin)
Completed
- Mycosis Fungoides
- Sézary Syndrome
- TSEB Therapy
- Brentuximab vedotin
-
Richmond, VirginiaVirginia Commonwealth University/Massey Cancer Center
Aug 29, 2019
Genetic Susceptibility to Radiation-Induced Skin Reactions in
Completed
- Breast Cancer
- +6 more
- DNA analysis
- +14 more
-
Winston-Salem, North CarolinaWake Forest University Comprehensive Cancer Center
Sep 21, 2021
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Houston
Active, not recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Quality-of-Life Assessment
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Mar 8, 2022
Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Spine, Stage IV Skin Melanoma Trial in Baltimore
Completed
- Metastatic Malignant Neoplasm in the Brain
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Baltimore, MarylandJohns Hopkins University/Sidney Kimmel Cancer Center
Nov 29, 2021
Cutaneous T Cell Lymphoma (CTCL), Mycosis Fungoides, Sézary Syndrome Trial in Stanford, New York, Philadelphia (NM-IL-12 and
Unknown status
- Cutaneous T Cell Lymphoma (CTCL)
- +2 more
- NM-IL-12 and TSEBT
-
Stanford, California
- +2 more
Nov 14, 2018
Treatment Positioning in Vulvar Cancer Radiation Therapy
Recruiting
- Radiation Toxicity
-
Amman, JordanKing Hussein Cancer Center
Aug 26, 2021
Vulvar Cancer Trial in Beijing (optical surface monitoring system)
Completed
- Vulvar Cancer
- optical surface monitoring system
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 2, 2023
Cone-Beam Computed Tomography Trial (Halcyon 4.0)
Not yet recruiting
- Cone-Beam Computed Tomography
- Halcyon 4.0
- (no location specified)
Sep 20, 2023
Physical Therapy Components for Maximum TKR Outcome
Completed
- Knee Osteoarthritis
- Knee Replacement
-
Worcester, MassachusettsUniversity of Massachusetts Medical SChool
Mar 11, 2021
Chondrosarcoma Trial in Houston (Proton Beam Therapy)
Active, not recruiting
- Chondrosarcoma
- Proton Beam Therapy
-
Houston, TexasMD Anderson Cancer Center
Aug 25, 2022
Metastatic Prostate Adenocarcinoma, Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Rochester
Active, not recruiting
- Metastatic Prostate Adenocarcinoma
- +6 more
- Intensity-Modulated Radiation Therapy
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 5, 2023
Early-stage Breast Cancer Trial in Brno (APBI, WBI)
Completed
- Early-stage Breast Cancer
- APBI
- WBI
-
Brno, Czech Republic, CzechiaMasaryk Memorial Cancer Institute
Aug 17, 2023